Nasdaq:US$38.93 (+1.39) | HKEX:HK$61.00 (+0.90) | AIM:£5.67 (+0.11)
Search Result
Previous Article   |   Next Article
Scientific Publications | 4 Jun 2021

ASCO 2021: A Multicenter Open-Label Phase 1 Study Evaluating the Safety and Tolerability of HMPL-306 in Patients with Locally Advanced or Metastatic Solid Tumors with IDH Mutations